List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 4395 studies with search of:   Germany
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A New Oral Treatment For Type II Diabetes Mellitus
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: GW0823093
2 Completed Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
Condition: Osteoarthritis, Knee
Intervention: Drug: GW406381
3 Completed Quality of Erection Study
Condition: Erectile Dysfunction
Intervention: Drug: Sildenafil Citrate
4 Active, not recruiting Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Methoxsalen;   Procedure: Extracorporeal Photopheresis
5 Active, not recruiting Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
6 Completed Safety Study of Apixaban in Recent Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Interventions: Drug: Apixaban;   Drug: Apixaban;   Drug: Placebo
7 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
8 Recruiting Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: rituximab;   Drug: yttrium Y 90 ibritumomab tiuxetan
9 Completed A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients
Condition: Overactive Bladder
Intervention: Drug: fesoterodine fumarate
10 Completed Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma
Intervention: Drug: BI 1744CL
11 Recruiting Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer
Condition: Pancreas Neoplasms
Interventions: Drug: Docetaxel;   Drug: Oxaliplatin
12 Active, not recruiting Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM1)
Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir (SCH 503034);   Biological: Peginterferon alfa-2b (SCH 54031);   Drug: Ribavirin (SCH 18908);   Drug: Boceprevir placebo
13 Not yet recruiting Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome
Conditions: Erectile Dysfunction;   Metabolic Syndrome
Interventions: Drug: Levitra (Vardenafil, BAY38-9456);   Drug: Placebo
14 Recruiting Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: tiotropium respimat;   Drug: placebo
15 Recruiting Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: alb-interferon alfa 2b;   Drug: peg-interferon
16 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
17 Completed Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition: NSCLC
Intervention: Drug: Gefitinib
18 Completed Chest Pain Pilot Study
Conditions: Chest Pain;   Gastroesophageal Reflux
Intervention: Drug: Esomeprazole
19 Completed Right Ventricular Failure in Congenital Heart Defects
Conditions: Heart Failure;   Congenital Heart Defects
Intervention:
20 Completed Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
Condition: Metrorrhagia
Interventions: Drug: Qlaira (BAY86-5027, SH T00658ID);   Drug: Placebo

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services